Senior React Native / Expo Engineer

Mochi Health cost: what you actually pay. Mochi Health cost, verified July 2026: the $79 membership plus medication makes the real all-in ~$178/mo semaglutide, ~$278/mo tirzepatide. Full breakdown. Nouri Editorial Team Medically reviewed by Amber Patel, MD · Jul 15, 2026 Medically reviewed by Amber Patel, MD · Last updated July 15, 2026. Nouri content is reviewed by licensed clinicians and updated as guidance changes. Disclosure: This is published by Nouri, a telehealth provider that also offers compounded GLP-1 medication and competes with Mochi Health. nouri has kept the facts sourced and dated, and noted where Mochi is the stronger choice. Mochi figures were verified on joinmochi.com and third-party sites as of July 2026 and may change - confirm current pricing at the source. The short answer: Mochi Health's real cost is two separate charges: a $79/month membership plus the medication. Compounded semaglutide is "starting at $99/month" and tirzepatide "starting at $199/month" - but neither includes the mandatory $79 membership, so the true all-in cost is about $178/month for semaglutide and $278/month for tirzepatide. The medication price is flat across doses, and Mochi can bill insurance for the visit side (not the compounded drug). The most common complaints, per the BBB, are billing and cancellation - largely because the membership and medication are two subscriptions you have to cancel separately. Compounded medications from any provider, including Mochi and Nouri, are not FDA-approved. * Two fees, not one: $79/month membership plus medication ($99 sema / $199 tirz) - the "from $99" headline leaves the membership out. * True all-in: about $178/month (semaglutide) or $278/month (tirzepatide) cash-pay. * Insurance angle: Mochi can bill insurance for the visit/membership side and help with prior authorizations - a real advantage if you're insured. The compounded drug itself stays cash-pay. * Cancellation trap: membership and medication are separate subscriptions; cancelling one doesn't cancel the other - the root of most billing complaints (BBB rating B-). * Genuine strengths: registered-dietitian support, flat price by dose, and a large body of positive Trustpilot reviews. How much does Mochi Health cost? Mochi's pricing splits into two charges that are easy to read as one. There's a membership fee - $79/month standard (a $39 first month for new customers), lower on prepaid terms - and a separate medication fee: compounded semaglutide starting at $99/month and compounded tirzepatide starting at $199/month, with shipping included. Put together, here's the true cash-pay cost, verified on joinmochi.com as of July 2026: | / | Membership | Medication | All-in / month | | Semaglutide | $79/mo | from $99/mo | ~$178/mo | | Tirzepatide | $79/mo | from $199/mo | ~$278/mo | Prices observed on joinmochi.com in July 2026; the $79 membership is added to the medication price to show all-in cost. A $39 first-month membership promo and multi-month prepay can lower the membership portion. Figures may change - verify at the source. Two fair points in Mochi's favor. The medication price is flat across the published dose range - it doesn't climb as you titrate up. And Mochi's membership does buy real things: video visits with a physician and a registered dietitian, ongoing support, and help with insurance prior authorizations. The membership isn't a junk fee; it's just a fee the "from $99" number doesn't show. Does Mochi Health take insurance? Partly, and this is one of Mochi's genuine advantages. Mochi can bill insurance for the visit and membership side (its "Wellness Plus" plan is built around qualifying insurance) and assists with prior authorizations and letters of medical necessity if you're pursuing a branded GLP-1 your plan might cover. What insurance does not cover is the compounded medication itself - that stays cash-pay at Mochi, as it does at every compounded-GLP-1 provider. So if you're insured and want help working your benefits, Mochi offers something a pure cash-pay provider can't. Is Mochi Health legit? Yes - Mochi is a real, licensed telehealth company connecting patients with board-certified physicians and registered dietitians, and it has a large base of positive reviews (a Trustpilot rating around 4.3-4.5 across more than 15,000 reviews as of July 2026). A complete picture also includes the friction: its BBB rating is B- (not accredited), with over 1,300 complaints in three years - most about billing and cancellation. Mochi also does not publicly name its current compounding pharmacy; its former in-house pharmacy in Washington closed in 2025 after a state regulatory action, and Mochi now uses outside partner pharmacies it identifies on the prescription label rather than on its site. And like several telehealth compounders, Mochi is named in ongoing marketing-related litigation from a brand manufacturer - a commercial dispute, not an FDA safety finding. None of this makes Mochi illegitimate; it means the pharmacy transparency and billing terms are worth checking before you enroll. How do you cancel Mochi Health? Carefully - this is the single biggest source of complaints. Because the membership and medication are billed as two separate subscriptions, cancelling one does not cancel the other, and many BBB complaints describe being charged the $79 membership after believing they'd cancelled. Prescription medication sales are generally final and non-refundable, and prepaid membership refunds depend on the plan terms. If you enroll, cancel both subscriptions explicitly and keep records. Mochi Health vs Nouri: an honest comparison. As a competing provider, here's the even-handed version, including where Mochi is the better pick. | / | Nouri | Mochi Health | | Membership fee | None | $79/month (separate) | | Semaglutide, all-in (best tier) | $120/mo (6-month) | ~$178/mo | | Tirzepatide, all-in (best tier) | $175/mo (6-month) | ~$278/mo | | Price at higher doses | Same, any dose | Flat by dose | | Insurance help | Cash-pay only | Bills visit side; PA support | | Compounding pharmacy | Named (Jungle Jim's, VialsRX) | Not publicly named | | Money-back guarantee | 30-day, on 3- & 6-month plans | Medication final-sale | Nouri and Mochi figures as of July 2026; verify current terms with each provider. Where Mochi is the stronger choice: if you're insured and want a provider that bills your benefits for the visit side and helps with prior authorizations, or if you want registered-dietitian-led care and a big review base, Mochi offers things Nouri doesn't. Where Nouri fits better: if you'd rather pay one all-in price with no separate membership, want tirzepatide at a lower all-in cost (~$175 vs ~$278), prefer a provider that names its pharmacy, or want a money-back guarantee. Nouri's model is built around one all-inclusive price with no membership fee; you can also see how the major compounded-GLP-1 providers compare on a published rubric or read its reviews of Ivim Health, Henry Meds, and Noom Med. Frequently asked questions. How much does Mochi Health cost per month? All-in, about $178/month for compounded semaglutide and $278/month for tirzepatide - that's the $79 membership plus the "from $99" (sema) or "from $199" (tirz) medication price. The headline medication price excludes the required membership. Is there a separate membership fee at Mochi? Yes - $79/month (a $39 first month for new customers), separate from and on top of the medication price. It covers video visits with a physician and registered dietitian, ongoing support, and insurance prior-authorization help. Mochi can bill insurance for the visit/membership side and help with prior authorizations, but the compounded medication itself is cash-pay - insurance doesn't cover the compounded drug at Mochi or any provider. Yes - it's a licensed telehealth provider with board-certified physicians and dietitians and a strong Trustpilot rating. Note a B- BBB rating with billing/cancellation complaints, and that Mochi doesn't publicly name its compounding pharmacy. Compounded GLP-1s from any provider are not FDA-approved. How do I cancel Mochi Health? Cancel both the membership and the medication subscriptions separately - cancelling one doesn't stop the other, which is the most common billing complaint. Medication is generally final-sale; keep records of your cancellation. Does Mochi's price change at higher doses? No - the medication price is flat across the published dose range, so titrating up doesn't raise the medication cost. Sources. * Mochi Health - pricing, medications, and FAQ pages (joinmochi.com), verified July 2026. joinmochi.com * Better Business Bureau - Mochi Health profile (B-, complaint categories). bbb.org * Trustpilot - Mochi Health reviews. trustpilot.com * FDA - FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov Comparing your options? See if you qualify with Nouri - one all-inclusive price with no separate membership fee, the same at any dose, from a named pharmacy. A five-minute intake, reviewed by a U.S.-licensed physician. This article is educational and reflects publicly available information about Mochi Health as of July 2026, which may change; verify current details with Mochi directly. Nouri is a competing telehealth provider - see the disclosure above. Compounded semaglutide and tirzepatide from any provider, including Mochi and Nouri, are not FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Zepbound, or Mounjaro. Nouri connects patients with licensed, independent physicians who make all prescribing decisions. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting or changing any medication or treatment. Licensed providers review patient assessments before making clinical decisions.

Are GLP-1 compounds safe? Not from this SF company and WA supplier, whistleblowers say. San Francisco-based weight loss startup Mochi Health partnered with pharmaceutical supplier, Aequita Pharmacy, to make GLP-1 compounded medication. State inspectors said Aequita's practices put people's safety at serious risk of harm and death. By Candice Nguyen and jeremy carroll - published june 4, 2026 - updated on june 5, 2026 at 11:56 am. GLP-1 medications are the hottest way to lose weight, but are all versions of the drug being marketed to you safe? A San Francisco-based weight loss startup, Mochi Health, is currently under a firestorm of scrutiny after working with pharmaceutical supplier Aqueita Pharmacy, which is in Kirkland, Washington. Partnering with the NBC station in Seattle, Washington, NBC Bay Area's Investigative Unit obtained public records showing whistleblowers went to state inspectors last year with a long list of patient safety complaints against Aequita with which Mochi's CEO Myra Ahmad was directly involved, they said. About 800 miles north of Mochi Health's headquarters at 333 Bush Street in San Francisco's Financial District, Mochi worked with Aequita to create GLP-1 compounded medication - at one point shipping 20,000 prescriptions to patients a week across the U.S., inspectors said in their findings. GLP-1 compounds are mixed by pharmacies to mimic brand name weight loss drugs. They're not FDA approved and the federal agency says they can be risky. Whistleblower reports, state findings As Ahmad took to social media talking about Mochi's growth and cheaper GLP-1 options for patients, Aequita pharmacy staff met with state inspectors in 2025 sharing ring videos from the facility. The videos appear to show Aequita's Head of Operations bring in unlicensed temporary workers to process prescriptions. The workers were picked up at home improvement store parking lots, according to six pharmacy employees who spoke with King 5, the NBC station in Seattle. "They would come over to our main facility...and actually handle the pharmaceuticals themselves," former Aequita lab manager Paul Meyers said. "They didn't have any state licensing." Regulators substantiated this complaint. They also found Aequita allowed untrained pharmacy assistants to compound the GLP-1 prescriptions and even directed the untrained pharmacy workers to compound the drugs without proper supervision. According to the state's report, whistleblowers told investigators Ahmad made a lot of the risky cost-cutting decisions at Aequita. For instance, one employee said Ahmad asked her to find the unlicensed temporary workers to specifically help "handle sterile compounded drugs and assemble kits for shipping and delivery to patients." Expired drugs, glass particles in vials, and Otter Pops Whistleblowers also told investigators, according to the state's report, that Ahmad and Aequita's Head of Operations decided to switch to cheap medicine vials that ended up breaking and shattering. In its determination, the state said witnesses reported seeing glass particles in some of the compounded product. It's unclear if it made it to patients. Also in their findings, inspectors said they discovered expired GLP-1 prescriptions that were going to be mailed out to patients. At least three had been expired for nearly nine months. Then, when the pharmacy ran out of ice packs to ship with the prescriptions because the medication needs to be kept cold during transit, inspectors said staffers alleged Ahmad suggested using frozen Otter Pop popsicles instead. Patients complained online that some of the popsicles leaked, spilling all over their medication, which the state mentioned in its report. Video: Regulators visit GLP-1 supplier unannounced In March 2025, Washington Department of Health inspectors visited one of Aequita's warehouses unannounced. They were responding to whistleblower reports, which included allegations the pharmacy moved GLP-1 drug ingredients across the street to hide them from inspection. Video from that visit obtained through a public records request by NBC Bay Area and the NBC station in Seattle shows a warehouse manager denying knowledge of any attempts to evade inspectors. "As far as I know there's nothing from the, the pharmacy...This is just storage for the packaging and stuff like that," the manager told regulators during the inspection. "Well, that's not necessarily true. I can tell you that...that's not packaging," an inspector responded opening a refrigerator next to the warehouse manager. In the refrigerator were bags of peptide base powders that, according to the state, Aequita used in its GLP-1 compounds. Business records show, months before, Myra Ahmad formed a wholesaler company, USA Distribution LLC, linked to that warehouse. Inspectors said USA Distribution wasn't licensed to be a wholesaler yet when inspectors found the powders. As a result of the inspection and its investigation into the whistleblower reports, the Washington Department of Health issued Aequita a Notice of Immediate Jeopardy. The regulator said the pharmacy's "deficient practices... have placed the health and safety of individuals at risk of serious injury, serious harm, serious impairment or death." Washington state officials said Aequita Pharmacy closed this past April. Mochi Health's CEO avoids questions, no response from Aequita NBC Bay Area's Investigative Unit has tried to speaking with someone at Aequita and Myra Ahmad about these allegations since April, but we haven't received a response. At the Livelong Women's Health Summit in San Francisco last March, NBC Bay Area tried speaking with Ahmad in person. She didn't answer any questions and walked away. In a booming industry that's marketing the hottest way to lose weight, Mochi is still offering GLP-1 compounded medication to patients, according to its website, working with other pharmacies nationwide. Candice Nguyen is the senior investigative reporter on this story. If you have a question or comment, email her at [email protected]. NBC Bay Area's senior investigator Candice Nguyen analyzed the controversy surrounding a Bay Area-based weight loss start-up after reports revealed multiple complaints.